The University of Southampton
University of Southampton Institutional Repository

Nisoldipine in cardiovascular disease : comparative studies with Nifedipine

Nisoldipine in cardiovascular disease : comparative studies with Nifedipine
Nisoldipine in cardiovascular disease : comparative studies with Nifedipine

A series of studies was undertaken to establish whether the pharmacological differences between nifedipine and nisoldipine were reflected in therapeutic benefit. The acute haemodynamic effects of incremental intravenous doses were compared in patients with coronary artery disease treated with atenolol. At doses with equivalent effects on heart rate, nisoldipine 2 μg/kg was a more effective vasodilator whilst nifedipine 10μg/kg caused a greater reduction in left ventricular stroke work. The anti-ischaemic effects of adding slow-release nifedipine 20 mg or nisoldipine 10mg, both twice daily, to atenolol monotherapy were compared in a double-blind placebo-controlled study of 24 patients with stable angina pectoris. Both drugs improved peak exercise capacity but this was not maintained 12 hourspost-dosing. Neither drug was associated with significant subjective benefit or reduction in the amount of ischaemia detected by ambulatory monitoring. The effects of nifedipine and nisoldipine on the finger temperature response to a standardised cold challenge were compared in patients with primary Raynaud's phenomenon using a technique developed for this purpose. No difference was detected between treatments, possibly due to wide variability and difficulty in precipitating attacks of vasospasm. In all studies, equipotent doses of nifedipine and nisoldipine had similar unwanted effects. It is concluded that nisoldipine is a more potent systemic vasodilator than nifedipine with significantly less direct negative inotropic action at equivalent doses. It may therefore be safer when administered with a β-adrenoceptor antagonist or to patients with impaired myocardial function. Doses with similar anti-ischaemic effects had similar durations of action and incidences of unwanted effects.

University of Southampton
Donaldson, Kirsteen Morag
bf8235a4-9cb8-43ec-bab4-1914a13d0dd4
Donaldson, Kirsteen Morag
bf8235a4-9cb8-43ec-bab4-1914a13d0dd4

Donaldson, Kirsteen Morag (1992) Nisoldipine in cardiovascular disease : comparative studies with Nifedipine. University of Southampton, Doctoral Thesis.

Record type: Thesis (Doctoral)

Abstract

A series of studies was undertaken to establish whether the pharmacological differences between nifedipine and nisoldipine were reflected in therapeutic benefit. The acute haemodynamic effects of incremental intravenous doses were compared in patients with coronary artery disease treated with atenolol. At doses with equivalent effects on heart rate, nisoldipine 2 μg/kg was a more effective vasodilator whilst nifedipine 10μg/kg caused a greater reduction in left ventricular stroke work. The anti-ischaemic effects of adding slow-release nifedipine 20 mg or nisoldipine 10mg, both twice daily, to atenolol monotherapy were compared in a double-blind placebo-controlled study of 24 patients with stable angina pectoris. Both drugs improved peak exercise capacity but this was not maintained 12 hourspost-dosing. Neither drug was associated with significant subjective benefit or reduction in the amount of ischaemia detected by ambulatory monitoring. The effects of nifedipine and nisoldipine on the finger temperature response to a standardised cold challenge were compared in patients with primary Raynaud's phenomenon using a technique developed for this purpose. No difference was detected between treatments, possibly due to wide variability and difficulty in precipitating attacks of vasospasm. In all studies, equipotent doses of nifedipine and nisoldipine had similar unwanted effects. It is concluded that nisoldipine is a more potent systemic vasodilator than nifedipine with significantly less direct negative inotropic action at equivalent doses. It may therefore be safer when administered with a β-adrenoceptor antagonist or to patients with impaired myocardial function. Doses with similar anti-ischaemic effects had similar durations of action and incidences of unwanted effects.

This record has no associated files available for download.

More information

Published date: 1992

Identifiers

Local EPrints ID: 461274
URI: http://eprints.soton.ac.uk/id/eprint/461274
PURE UUID: b925ad59-1d2c-4aba-bacb-f42132893b53

Catalogue record

Date deposited: 04 Jul 2022 18:42
Last modified: 23 Jul 2022 01:08

Export record

Contributors

Author: Kirsteen Morag Donaldson

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×